U.S. Markets closed

Novartis in Q3 2018: Analysts Expect Revenue Growth

Mike Benson
Novartis in Q3 2018: Analysts Expect Revenue Growth

Analysts expect Novartis’s revenues to increase ~4.9% to $13.02 billion in the third quarter of 2018. There has been operating revenue growth for all three of its segments in the quarter. Analysts expect Novartis’s Innovative Medicines segment to report revenue growth in the third quarter of 2018 compared to the third quarter of 2017.